1. Home
  2. KRT vs JANX Comparison

KRT vs JANX Comparison

Compare KRT & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karat Packaging Inc.

KRT

Karat Packaging Inc.

N/A

Current Price

$52.63

Market Cap

1.1B

Sector

Industrials

ML Signal

N/A

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

N/A

Current Price

$17.69

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRT
JANX
Founded
2000
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
KRT
JANX
Price
$52.63
$17.69
Analyst Decision
Buy
Strong Buy
Analyst Count
3
18
Target Price
★ $46.50
$33.81
AVG Volume (30 Days)
133.5K
★ 722.2K
Earning Date
11-05-2026
11-17-2026
Dividend Yield
★ 3.54%
N/A
EPS Growth
★ 4.70
N/A
EPS
★ 1.80
N/A
Revenue
★ $467,743,000.00
$10,000,000.00
Revenue This Year
$12.22
$194.24
Revenue Next Year
$8.47
N/A
P/E Ratio
$29.72
★ N/A
Revenue Growth
★ 10.67
N/A
52 Week Low
$20.61
$12.12
52 Week High
$56.06
$35.34

Technical Indicators

Market Signals
Indicator
KRT
JANX
Relative Strength Index (RSI) 49.90 54.90
Support Level $52.21 $15.90
Resistance Level $55.36 $19.16
Average True Range (ATR) 1.46 0.76
MACD -0.29 0.08
Stochastic Oscillator 17.95 65.11

Price Performance

Historical Comparison
KRT
JANX

About KRT Karat Packaging Inc.

Karat Packaging Inc is a distributor and manufacturer of disposable foodservice products and related items, including containers, bags, tableware, cups, lids, cutlery, straws, specialty beverage ingredients, gloves, and janitorial supplies, available in plastic, paper, biopolymer-based, and other compostable forms. The Company focuses on environmentally friendly products and provides customized solutions including product development, design, printing, and logistics services. It serves customers through chains and distributors, retail, and e-commerce/online, and operates in the manufacturing and distribution of single-use food and beverage products, as well as specialty food and beverage products and restaurant and warehouse supplies.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: